10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...
10x Genomics Inc - Class A (TXG) shares closed today at 0.1% above its 52 week low of $104.69, giving the company a market cap of $9B. The stock is currently down 29.6% year-to-date, down 40.3% over ...
Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...
Company taps John R. Quain, Norbert Gleicher, MD, Carol Hanna, Ph.D, Jon Hennebold, Ph.D, and Stephen Turner, Ph.D to its world-class team to advance responsible genomic medicine. NEW YORK, October 30 ...
Since the beginning of the semester, students in Biology 144 have been creating documentary projects related to genomics. The documentaries will be uploaded to YouTube on Wednesday. A branch of ...
The first-ever sequencing of the human genome cost $2.7 billion. Today, the service 23andMe offers personal genome sequencing for less than $200. And for students enrolled in Cornell’s personal ...
New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer's Disease (AD). The research demonstrates that circRNAs ...
Rochester Institute of Technology students are getting hands-on experience interpreting raw genetic data provided by the Genomics Education Partnership at Washington University, home to one of the few ...
10x Genomics Inc - Class A (TXG) shares closed today at 1.5% above its 52 week low of $117.01, giving the company a market cap of $11B. The stock is currently down 18.1% year-to-date, down 27.2% over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback